{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:36:32Z","timestamp":1791041792715,"version":"4.1.0"},"reference-count":77,"publisher":"Society of Nuclear Medicine","issue":"Supplement 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.2967\/jnumed.121.263197","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T16:11:10Z","timestamp":1654099870000},"page":"27S-32S","source":"Crossref","is-referenced-by-count":44,"title":["Imaging Dopaminergic Neurotransmission in Neurodegenerative Disorders"],"prefix":"10.2967","volume":"63","author":[{"given":"Elon D.","family":"Wallert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsmarieke","family":"van de Giessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remco J.J.","family":"Knol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn","family":"Beudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob M.A.","family":"de Bie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Booij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2022,6,1]]},"reference":[{"key":"2022060616200897000_63.Supplement_1.27S.1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/122.8.1449"},{"key":"2022060616200897000_63.Supplement_1.27S.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198804073181402"},{"key":"2022060616200897000_63.Supplement_1.27S.3","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25975"},{"key":"2022060616200897000_63.Supplement_1.27S.4","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.14698"},{"key":"2022060616200897000_63.Supplement_1.27S.5","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25103"},{"key":"2022060616200897000_63.Supplement_1.27S.6","doi-asserted-by":"crossref","unstructured":"Booij J van Wieringen J-P van de Giessen E Knol RJJ Finnema SJ . PET and SPECT imaging of the central dopamine system in humans. In: Dierckx RAJO Otte A de Vries EFJ van Waarde A Lammertsma AA , eds. PET and SPECT of Neurobiological Systems . Springer; 2021:295\u2013318.","DOI":"10.1007\/978-3-030-53176-8_11"},{"key":"2022060616200897000_63.Supplement_1.27S.7","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20160"},{"key":"2022060616200897000_63.Supplement_1.27S.8","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(13)70056-5"},{"key":"2022060616200897000_63.Supplement_1.27S.9","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-324266"},{"key":"2022060616200897000_63.Supplement_1.27S.10","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-017-1684-z"},{"key":"2022060616200897000_63.Supplement_1.27S.11","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-015-0087-1"},{"key":"2022060616200897000_63.Supplement_1.27S.12","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22108"},{"key":"2022060616200897000_63.Supplement_1.27S.13","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3233\/JPD-202506","article-title":"Impact of DaTscan imaging on clinical decision making in clinically uncertain Parkinson\u2019s disease","volume":"11","author":"Isaacson","year":"2021","journal-title":"J Parkinsons Dis."},{"key":"2022060616200897000_63.Supplement_1.27S.14","doi-asserted-by":"crossref","unstructured":"Bega D Kuo PH Chalkidou A . Clinical utility of DaTscan in patients with suspected Parkinsonian syndrome: a systematic review and meta-analysis. NPJ Parkinsons Dis. 2021;7:43.","DOI":"10.1038\/s41531-021-00185-8"},{"key":"2022060616200897000_63.Supplement_1.27S.15","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000641"},{"key":"2022060616200897000_63.Supplement_1.27S.16","doi-asserted-by":"crossref","first-page":"825","DOI":"10.3233\/JPD-199003","article-title":"The qualification of an enrichment biomarker for clinical trials targeting early stages of Parkinson\u2019s disease","volume":"9","author":"Stephenson","year":"2019","journal-title":"J Parkinsons Dis."},{"key":"2022060616200897000_63.Supplement_1.27S.17","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.189266"},{"key":"2022060616200897000_63.Supplement_1.27S.18","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.110106"},{"key":"2022060616200897000_63.Supplement_1.27S.19","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.227140"},{"key":"2022060616200897000_63.Supplement_1.27S.20","doi-asserted-by":"publisher","DOI":"10.1002\/mds.1256"},{"key":"2022060616200897000_63.Supplement_1.27S.21","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.182139"},{"key":"2022060616200897000_63.Supplement_1.27S.22","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.111.095224"},{"key":"2022060616200897000_63.Supplement_1.27S.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2014.04.022"},{"key":"2022060616200897000_63.Supplement_1.27S.24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018301"},{"key":"2022060616200897000_63.Supplement_1.27S.25","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(07)70057-1"},{"key":"2022060616200897000_63.Supplement_1.27S.26","doi-asserted-by":"crossref","first-page":"e476","DOI":"10.1212\/WNL.0000000000007855","article-title":"Neuropathologic correlates of amyloid and dopamine transporter imaging in Lewy body disease","volume":"93","author":"Shirvan","year":"2019","journal-title":"Neurology."},{"key":"2022060616200897000_63.Supplement_1.27S.27","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.61.6.919"},{"key":"2022060616200897000_63.Supplement_1.27S.28","first-page":"CD010633","article-title":"Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies","volume":"1","author":"McCleery","year":"2015","journal-title":"Cochrane Database Syst Rev."},{"key":"2022060616200897000_63.Supplement_1.27S.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2011.09.015"},{"key":"2022060616200897000_63.Supplement_1.27S.30","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1007\/s00259-016-3312-x","article-title":"[123]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies","volume":"43","author":"van der Zande","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2022060616200897000_63.Supplement_1.27S.31","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aws211"},{"key":"2022060616200897000_63.Supplement_1.27S.32","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1212\/WNL.0000000000003512","article-title":"Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB","volume":"88","author":"Thomas","year":"2017","journal-title":"Neurology."},{"key":"2022060616200897000_63.Supplement_1.27S.33","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000424"},{"key":"2022060616200897000_63.Supplement_1.27S.34","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26424"},{"key":"2022060616200897000_63.Supplement_1.27S.35","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1007\/s00259-020-04817-8","article-title":"EANM practice guideline\/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0","volume":"47","author":"Morbelli","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2022060616200897000_63.Supplement_1.27S.36","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-008-0989-5"},{"key":"2022060616200897000_63.Supplement_1.27S.37","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/jamaneurol.2014.290","article-title":"Correlation of Parkinson disease severity and 18F-DTBZ positron emission tomography","volume":"71","author":"Hsiao","year":"2014","journal-title":"JAMA Neurol."},{"key":"2022060616200897000_63.Supplement_1.27S.38","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.109.070094"},{"key":"2022060616200897000_63.Supplement_1.27S.39","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jcbfm.9600276"},{"key":"2022060616200897000_63.Supplement_1.27S.40","doi-asserted-by":"publisher","DOI":"10.1159\/000334535"},{"key":"2022060616200897000_63.Supplement_1.27S.41","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-025533"},{"key":"2022060616200897000_63.Supplement_1.27S.42","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(99)02205-2"},{"key":"2022060616200897000_63.Supplement_1.27S.43","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410320516"},{"key":"2022060616200897000_63.Supplement_1.27S.44","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/mds.28632","article-title":"Dopamine receptors in Parkinson\u2019s disease: a meta-analysis of imaging studies","volume":"36","author":"Kaasinen","year":"2021","journal-title":"Mov Disord."},{"key":"2022060616200897000_63.Supplement_1.27S.45","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31826c1b0a"},{"key":"2022060616200897000_63.Supplement_1.27S.46","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70002-8"},{"key":"2022060616200897000_63.Supplement_1.27S.47","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1007\/s00259-021-05302-6","article-title":"Neuropathological correlation supports automated image-based differential diagnosis in parkinsonism","volume":"48","author":"Schindlbeck","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2022060616200897000_63.Supplement_1.27S.48","first-page":"183","article-title":"Single-photon emission tomography and dopamine transporter imaging in Parkinson\u2019s disease","volume":"91","author":"Marek","year":"2003","journal-title":"Adv Neurol."},{"key":"2022060616200897000_63.Supplement_1.27S.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2011.09.005"},{"key":"2022060616200897000_63.Supplement_1.27S.50","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.13.1653"},{"key":"2022060616200897000_63.Supplement_1.27S.51","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1186\/s12883-021-02470-8","article-title":"Evaluating dopamine transporter imaging as an enrichment biomarker in a phase 2 Parkinson\u2019s disease trial","volume":"21","author":"Hutchison","year":"2021","journal-title":"BMC Neurol."},{"key":"2022060616200897000_63.Supplement_1.27S.52","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1002\/mds.26051","article-title":"Cognitive executive impairment and dopaminergic deficits in de novo Parkinson\u2019s disease","volume":"29","author":"Siepel","year":"2014","journal-title":"Mov Disord."},{"key":"2022060616200897000_63.Supplement_1.27S.53","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27492"},{"key":"2022060616200897000_63.Supplement_1.27S.54","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1001\/jamaneurol.2013.6233","article-title":"Parkinson disease subtypes","volume":"71","author":"Thenganatt","year":"2014","journal-title":"JAMA Neurol."},{"key":"2022060616200897000_63.Supplement_1.27S.55","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2017-315813"},{"key":"2022060616200897000_63.Supplement_1.27S.56","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2796-5"},{"key":"2022060616200897000_63.Supplement_1.27S.57","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2006.103788"},{"key":"2022060616200897000_63.Supplement_1.27S.58","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa238"},{"key":"2022060616200897000_63.Supplement_1.27S.59","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3233\/JPD-212761","article-title":"Asymmetric dopaminergic dysfunction in brain-first versus body-first Parkinson\u2019s disease subtypes","volume":"11","author":"Knudsen","year":"2021","journal-title":"J Parkinsons Dis."},{"key":"2022060616200897000_63.Supplement_1.27S.60","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/ane.12932","article-title":"Patterns of dopamine transporter imaging in subtypes of multiple system atrophy","volume":"138","author":"Bu","year":"2018","journal-title":"Acta Neurol Scand."},{"key":"2022060616200897000_63.Supplement_1.27S.61","first-page":"359","article-title":"Quantification of striatal dopamine transporters with 123I-FP-CIT SPECT is influenced by the selective serotonin reuptake inhibitor paroxetine: a double-blind, placebo-controlled, crossover study in healthy control subjects","volume":"48","author":"Booij","year":"2007","journal-title":"J Nucl Med."},{"key":"2022060616200897000_63.Supplement_1.27S.62","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.110.078337"},{"key":"2022060616200897000_63.Supplement_1.27S.63","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.parkreldis.2020.07.008","article-title":"Extrastriatal 123I-FP-CIT SPECT impairment in degenerative parkinsonisms","volume":"78","author":"Nicastro","year":"2020","journal-title":"Parkinsonism Relat Disord."},{"key":"2022060616200897000_63.Supplement_1.27S.64","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1007\/s00259-019-04324-5","article-title":"Extrastriatal dopaminergic and serotonergic pathways in Parkinson\u2019s disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study","volume":"46","author":"Pilotto","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2022060616200897000_63.Supplement_1.27S.65","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1007\/s00259-019-04587-y","article-title":"Quantification and discriminative power of 18F-FE-PE2I PET in patients with Parkinson\u2019s disease","volume":"47","author":"Delva","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2022060616200897000_63.Supplement_1.27S.66","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.114.152421"},{"key":"2022060616200897000_63.Supplement_1.27S.67","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13550-018-0450-0","article-title":"Dopamine transporter imaging with [18F]FE-PE2I PET and [123I]FP-CIT SPECT: a clinical comparison","volume":"8","author":"Jakobson Mo","year":"2018","journal-title":"EJNMMI Res."},{"key":"2022060616200897000_63.Supplement_1.27S.68","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-014-7302-2"},{"key":"2022060616200897000_63.Supplement_1.27S.69","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10526"},{"key":"2022060616200897000_63.Supplement_1.27S.70","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2013.11.001"},{"key":"2022060616200897000_63.Supplement_1.27S.71","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr003"},{"key":"2022060616200897000_63.Supplement_1.27S.72","doi-asserted-by":"publisher","DOI":"10.1126\/science.1060937"},{"key":"2022060616200897000_63.Supplement_1.27S.73","doi-asserted-by":"publisher","DOI":"10.1097\/01.wnr.0000227984.84927.a7"},{"key":"2022060616200897000_63.Supplement_1.27S.74","doi-asserted-by":"crossref","first-page":"109752","DOI":"10.1016\/j.ejrad.2021.109752","article-title":"Imaging of the dopamine system with focus on pharmacological MRI and neuromelanin imaging","volume":"140","author":"Reneman","year":"2021","journal-title":"Eur J Radiol."},{"key":"2022060616200897000_63.Supplement_1.27S.75","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1807983116"},{"key":"2022060616200897000_63.Supplement_1.27S.76","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1007\/s00330-020-07240-7","article-title":"Diagnostic performance of neuromelanin-sensitive magnetic resonance imaging for patients with Parkinson\u2019s disease and factor analysis for its heterogeneity: a systematic review and meta-analysis","volume":"31","author":"Cho","year":"2021","journal-title":"Eur Radiol."},{"key":"2022060616200897000_63.Supplement_1.27S.77","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.parkreldis.2021.05.002","article-title":"Neuromelanin-sensitive magnetic resonance imaging in disease differentiation for parkinsonism or neurodegenerative disease affecting the basal ganglia","volume":"87","author":"Matsuura","year":"2021","journal-title":"Parkinsonism Relat Disord."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.121.263197","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T23:21:13Z","timestamp":1654557673000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.121.263197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":77,"journal-issue":{"issue":"Supplement 1","published-online":{"date-parts":[[2022,6,1]]},"published-print":{"date-parts":[[2022,6]]}},"alternative-id":["10.2967\/jnumed.121.263197"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.121.263197","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6]]}}}